Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
CURRENT ASSETS:    
Cash and cash equivalents $ 43,173,000 $ 25,505,000
Marketable securities, at fair value 17,667,000 19,366,000
Other current assets 26,000 120,000
TOTAL CURRENT ASSETS 60,866,000 44,991,000
OTHER ASSETS:    
Deferred tax assets, net 954,000
Patents, net of accumulated amortization 1,444,000 1,578,000
Equity investment 3,018,000 3,650,000
Convertible note investment 1,000,000
Security deposits 13,000 21,000
Total Other Assets 5,475,000 6,203,000
TOTAL ASSETS 66,341,000 51,194,000
CURRENT LIABILITIES:    
Income taxes payable 3,036,000
Accounts payable 399,000 597,000
Accrued contingency fees and related costs 46,000 932,000
Accrued payroll 277,000
Other accrued expenses 134,000 226,000
Total Current Liabilities 3,615,000 2,032,000
LONG TERM LIABILITIES:    
Deferred tax liability 680,000
TOTAL LIABILITIES 4,295,000 2,032,000
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at September 30,2021 and December 31,2020
Common stock, $0.01 par value; authorized 50,000,000 shares; 24,099,629 and 24,105,879 shares issued and outstanding at September 30,2021 and December 31,2020,respectively 241,000 241,000
Additional paid-in capital 66,307,000 66,124,000
Accumulated deficit  (4,496,000) (17,193,000)
Accumulated other comprehensive loss (6,000) (10,000)
TOTAL STOCKHOLDERS’ EQUITY 62,046,000 49,162,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 66,341,000 $ 51,194,000